Which feature best distinguishes Type 2 Diabetes Mellitus from Hypertension in the context of NPCDCS screening and management priorities?

Explanation

## Distinguishing Features: Type 2 DM vs Hypertension ### Key Monitoring & Diagnostic Differences **Key Point:** The fundamental distinction between Type 2 DM and Hypertension under NPCDCS lies in their monitoring parameters and diagnostic criteria, not in treatability or reversibility. | Feature | Type 2 Diabetes | Hypertension | |---------|-----------------|---------------| | **Screening Parameter** | Fasting blood glucose (FBG), postprandial glucose, HbA1c | Systolic/Diastolic BP (office, home, or ambulatory) | | **Diagnostic Threshold** | FBG ≥126 mg/dL or 2-hr PPBG ≥200 mg/dL | SBP ≥140 or DBP ≥90 mmHg (or <130/80 in high-risk) | | **Monitoring Frequency** | Regular (quarterly to annually) glucose monitoring | Regular BP monitoring (home or clinic) | | **Reversibility** | Can be managed/controlled with lifestyle; not "cured" but remission possible | Can be controlled; some cases reversible with weight loss | | **Initial Management** | Lifestyle + metformin (first-line pharmacotherapy) | Lifestyle ± antihypertensives | ### Why Option 1 (Correct) is the Best Discriminator **High-Yield:** Under NPCDCS, Type 2 DM screening specifically requires measurement of **fasting and postprandial blood glucose or HbA1c**, whereas hypertension screening relies on **blood pressure measurement alone**. This is the operationally distinct feature in public health surveillance and screening protocols. **Clinical Pearl:** NPCDCS emphasizes opportunistic screening at primary health centers. The diagnostic modality itself (glucose vs. BP measurement) is the clearest discriminator between these two conditions in a resource-constrained setting. ### Why Other Options Are Incorrect - **Option 0 ("Both require lifelong pharmacological intervention"):** False premise. Many patients with Type 2 DM and hypertension can be managed with lifestyle modification alone, especially in early stages. Neither universally requires "lifelong" drugs from diagnosis. - **Option 2 ("Hypertension is reversible... diabetes always requires insulin"):** Misleading. Not all Type 2 DM requires insulin; many are controlled on oral agents or lifestyle alone. Hypertension is also not always reversible. - **Option 3 ("Diabetes screening annually, hypertension every 5 years"):** Incorrect frequency. NPCDCS recommends screening for both conditions opportunistically at every visit; no such rigid 5-year interval exists for hypertension in the Indian guidelines. [cite:Park 26e Ch 11]